Drug Therapy of Lipid Disorders: Benefits and Limitations in Elderly Patients.
Pharmacologic therapy of lipid disorders has become an established means to reduce cardiovascular morbidity and mortality. Compared to middle-aged individuals with hyperlipidemia, the use of such treatment in the elderly population has been controversial, as there is only scant data from large clinical trials that can be applied to this group. Therefore, current recommendations for specific anti-lipid drug use in older individuals must weigh each drug's potential benefits against the potential treatment risks that are inherent to this age group.